ENDOPROBES
510(k) K922917
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK922917 | Date28 Sep 1992 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- GEX
- Device Class
- Class II
- Regulation
- 21 CFR Part 878.4810
- Advisory Committee
- General, Plastic Surgery
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
ENDOPROBES are medical devices used for endoscopic procedures. They are designed to provide visualization and access during minimally invasive surgical interventions.
The device is supplied by Endooptiks, Inc. and has received FDA 510(k) clearance with the product code GEX. It is intended for use in general and plastic surgery settings, with specific model number K922917.
Other devices from Endooptiks, Inc.
Questions
AI-generated answers, 19 Sep 2026
What is the intended use of ENDOPROBES?
ENDOPROBES are designed to provide visualization and access during minimally invasive surgical interventions in general and plastic surgery settings, as specified in the device description.
How is ENDOPROBES supplied and by whom?
ENDOPROBES are supplied by Endooptiks, Inc., located at 28 Marigold Ln., Marlboro, NJ 07746, United States, as indicated in the manufacturer and address fields of the device data.
What regulatory pathway was used for ENDOPROBES clearance?
ENDOPROBES received FDA 510(k) clearance through a traditional review process, as stated in the AUTHORIZATIONS and clearance_type fields, with decision code SESE indicating substantial equivalence.
What is the product code and model number for ENDOPROBES?
ENDOPROBES have the product code GEX and the specific model number K922917, as listed in the product_code and k_number fields of the device data.
When was ENDOPROBES cleared by the FDA?
ENDOPROBES received FDA clearance on September 28, 1992, as shown in the decision_date field, following submission on June 17, 1992, per the date_received field.